Biden’s Admin Now On Track To Have Enough Vaccine Supply For Every Adult In America

President Joe Biden said Tuesday that the U.S. expects to take delivery of enough coronavirus vaccines for all adults by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved shot.

With the bolstered supply, Biden also announced he would be using the powers of the federal government to direct all states to prioritize vaccinating teachers, and said the federal government would provide the doses directly through its pharmacy program. He challenged states to administer at least one dose of the vaccine to all educators by the end of March as part of his administration’s efforts to reopen more schools across the nation.

Image

Highlights:

  • Biden has asked the DOD daily logistically support to strengthen J&J’s efforts.
  • The President said, we are now on tract to have enough of vaccine supply, for every adult in America by the end of May.
Group Number
18 years and over 209,128,094 74.3%
Male 100,994,367 35.9%
Female 108,133,727 38.4%
21 years and over 196,899,193

70.0%

  • The Biden’s admin is increasing place where people get vaccinated.
  • “Let’s treat in-person learning as the essential service that it is,” Biden said. Teachers will be able to sign up directly through the participating retail pharmacies in their local area, the administration said.
  • More than 800,000 doses of the J&J vaccine will also be distributed this week to pharmacies, on top of the 2.4 million they are now getting of the Pfizer and Moderna vaccine supply, according to the administration.
  • CDC issued new guidelines in how to reopen schools safely. Its a roadmap that will enable schools to have the resources to open safely.
  • Schools will reopen if the right steps are taken, added Biden.

Biden’s Call With Governors:

In hopes of increasing vaccinations even further. the Biden administration told governors to make preparations to administer even more doses in the coming weeks. More shots are also heading toward the federally backed program to administer doses in retail pharmacies, which federal officials believe can double or triple their pace of vaccination. More than 800,000 doses of the J&J vaccine will also be distributed this week to pharmacies, on top of the 2.4 million they are now getting of the Pfizer and Moderna vaccine supply.

Those pharmacies will be key in getting the vaccines into the arms of teachers — particularly in the roughly 20 states where they have not been prioritized for shots — which will help reopen schools to better educate students who have been at risk of falling behind during the pandemic and reduce the burden on parents who have had to choose between childcare and a job.

“Let’s treat in-person learning as the essential service that it is,” Biden said. Teachers will be able to sign up directly through the participating retail pharmacies in their local area, the administration said.

On a call with governors Tuesday, White House coronavirus coordinator Jeff Zients said states should prepare for administering 16-17 million total weekly doses of Pfizer and Moderna vaccines by the end of March, climbing to 17-18 million weekly by early April. The supply of J&J doses to states, expected to dip after the initial shipment this week, will climb to 4-6 million weekly doses by the end of March and 5-6 million doses weekly through the end of April.

White House Press Secretary Jen Psaki Announced:

White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously. States will also receive 2.8 million doses of the J&J shot this week.

Psaki said that an “across the administration effort” was required to get the two historic rivals to work together on the vaccines, even though conversations between the two companies have been going on for months.

The Partners Are Saying:

Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company has promised to deliver 100 million doses by the end of June.

Before the approval of the J&J shot, Biden had suggested that it would take until the end of July to have enough vaccine for every adult in the U.S.

Facing questions about the company’s slipping delivery schedule, J&J Vice President Richard Nettles told lawmakers on Capitol Hill last week that the company had faced “significant challenges” because of its “highly complex” manufacturing process.

The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics. The news was first reported by The Washington Post.

“Merck remains steadfast in our commitment to contribute to the global response to the pandemic and to preparing to address future pandemics,” the Kenilworth, New Jersey-based company said in a statement.

 

Source:AP contributed to this article.

Leave a Reply

Your email address will not be published. Required fields are marked *